Clinical features of hypertrophic cardiomyopathy in the young

Cardiology in the Young

Volumn 12, Issue 2, 2002, Pages 147-152

  Bruno, Eva ^a   Maisuls, Héctor ^a   Juaneda, Ernesto ^a   Moreyra, Eduardo ^b   Alday, Luis E ^c,d  

^a Hospital of Nino Jesus   (Argentina)

^b UNIVERSIDAD NACIONAL DE CÓRDOBA   (Argentina)

^c HOSPITAL PRIVADO   (Argentina)

^d NONE   (Argentina)

Author keywords

Hypertrophic cardiomyopathy; Secondary hypertrophic cardiomyopathy; Sudden death

Indexed keywords

AGING; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CONGENITAL HEART DISEASE; CONTROLLED STUDY; HEART PACING; HEART TRANSPLANTATION; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MORTALITY; RADIOFREQUENCY ABLATION; SUDDEN DEATH; ADOLESCENT; AGE DISTRIBUTION; ARGENTINA; COHORT ANALYSIS; COMPARATIVE STUDY; ECHOCARDIOGRAPHY; FEMALE; HEART CATHETERIZATION; HOSPITALIZATION; MALE; METHODOLOGY; PREVALENCE; PROBABILITY; PROGNOSIS; RETROSPECTIVE STUDY; RISK FACTOR; SEX RATIO; SURVIVAL RATE;

ADOLESCENT; AGE DISTRIBUTION; ARGENTINA; CARDIOMYOPATHY, HYPERTROPHIC; CHILD; COHORT STUDIES; DEATH, SUDDEN, CARDIAC; ECHOCARDIOGRAPHY; FEMALE; HEART CATHETERIZATION; HUMANS; MALE; PREVALENCE; PROBABILITY; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; SURVIVAL RATE;

EID: 0036510957     PISSN: 10479511     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1047951102000306     Document Type: Article

References (40)

1. Brock RC. Functional obstruction of the left ventricle. Guys Hosp Rep 1957; 106: 221-238.
2. Teare RD. Asymmetrical hypertrophy of the heart in young adults. Br Heart J 1958; 20: 1-8.
3. Wigle ED, Rakowski H, Kimball BP, Williams WG. Hypertrophic cardiomyopathy. Clinical spectrum and treatment. Circulation 1995; 92: 1680-1692.
4. Maron BJ, Edwards JE, Henry WL, Clark CE, Bingle GJ, Epstein SE. Asymmetric septal hypertrophy in infancy. Circulation 1974; 50: 809-820.
5. Maron BJ, Tajik AJ, Ruttenberg HD, et al. Hypertrophic cardiomyopathy in infants: clinical features and natural history. Circulation 1982; 65: 7-17.
6. Schaffer MS, Freedom RM, Rowe RD. Hypertrophic cardiomyopathy presenting before 2 years of age in 13 patients. Pediatr Cardiol 1983; 4: 113-118.
7. Fiddler GI, Tajik AJ, Weidman WH, McGoon DC, Ritter DG, Giuliani ER. Idiopathic hypertrophic subaortic stenosis in the young. Am J Cardiol 1978; 42: 793-799.
8. Romeo F, Cianfrocca C, Pelliccia F, Colloridi V, Cristofani R, Reale A. Long-term prognosis in children with hypertrophic cardiomyopathy: an analysis of 37 patients aged <14 years at diagnosis. Clin Cardiol 1990; 13: 101-107.
9. Comparto C, Pipitone S, Sperandeo V, Mongiovi M. Clinical profile and prognosis of hypertrophic cardiomyopathy when first diagnosed in infancy as opposed to childhood. Cardiol Young 1997; 7: 410-416.
10. Maron BJ, Spirito P, Wesley Y, Arce J. Development and progression of left ventricular hypertrophy in children with hypertrophic cardiomyopathy. N Engl J Med 1986; 315: 610-614.
11. Maron BJ, Roberts WC, Epstein SE. Sudden death in hypertrophic cardiomyopathy: a profile of 78 patients. Circulation 1982; 65: 1388-1394.
12. McKenna WJ, Deanfield J, Faruqui A, England D, Oakley C, Goodwin J. Prognosis in hypertrophic cardiomyopathy: role of age and clinical, electrocardiographic and hemodynamic features. Am J Cardiol 1981; 47: 532-538.
13. Alday LE, Moreyra E. Secondary hypertrophic cardiomyopathy in infancy and childhood. Am Heart J 1984; 108: 996-1000.
14. Maron BJ, Epstein SE. Hypertrophic cardiomyopathy. Recent observations regarding the specificity of three hallmarks of the disease: asymmetric septal hypertrophy, septal disorganization and systolic anterior motion of the anterior mitral leaflet. Am J Cardiol 1980; 45: 141-154.
15. McKenna WJ, Spirito P, Desnos N, Dubourg O, Komajda M. Experience from clinical genetics in hypertrophic cardiomyopathy: proposal for new diagnostic criteria in adult members of affected families. Heart 1997; 77: 130-132.
16. Henry WL, Clark CE, Epstein SE. Asymmetric septal hypertrophy. Echocardiographic identification of the pathognomonic anatomic abnormality of idiopathic hypertrophic subaortic stenosis. Circulation 1973; 47: 225-233.
17. Klues HG, Schiffers A, Maron BJ. Phenotypic spectrum and patterns of left ventricular hypertrophy in hypertrophic cardiomyopathy: morphologic observations and significance as assessed by 2D echocardiography in 600 patients. J Am Coll Cardiol 1995; 26: 1699-1708.
18. Maron BJ, Anan TJ, Roberts WC. Quantitative analysis of the distribution of cardiac muscle cell disorganization in the left ventricular wall of patients with hypertrophic cardiomyopathy. Circulation 1981; 63: 882-894.
19. Braunwald E, Lambrew CT, Rockoff SD, Ross Jr J, Morrow AG. Idiopathic hypertrophic subaortic stenosis. I. A description of the disease based upon an analysis of 64 patients. Circulation 1964; 30 (Suppl IV): 3-119.
20. Protonotarios N, Tsatsopoulou A, Patsourakos P, et al. Cardiac abnormalities in familial palmoplantar keratosis. Br Heart J 1986; 56: 321-326.
21. Somerville J, Becu L. Congenital heart disease associated with hypertrophic cardiomyopathy. Br Heart J 1978; 40: 1034-1039.
22. King SM, Vogel JH, Blount SG. Idiopathic muscular subvalvular aortic stenosis with associated congenital cardiovascular lesions. Am J Cardiol 1965; 15: 837-847.
23. Van der Hauwaert LG, Fryns JP, Dumoulin M, Logghe N. Cardiovascular malformations in Turner's and Noonan's syndrome. Br Heart J 1978; 40: 500-509.
24. Alday LE, Moreyra E, Juaneda E, Zavanella C. Hypertrophic cardiomyopathy in a child with tetralogy of Fallot. J Cardiovasc Ultrasonography 1985; 4: 87-90.
25. Nora JJ, Nora AH, Sinha AK, Spangler RD, Lubs HA. The Ulrich-Noonan syndrome (Turner phenotype). Am J Dis Child 1974; 127: 48-55.
26. Maron BJ, Mulvihill JJ. The genetics of hypertrophic cardiomyopathy. Ann Int Med 1986; 105: 610-613.
27. Maron BJ, Nichols PF, Pickle LW, Wesley YE, Mulvihill JJ. Patterns of inheritance in hypertrophic cardiomyopathy. Assessment by M mode and two-dimensional echocardiography. Am J Cardiol 1984; 53: 1087-1094.
28. Maron BJ, Bonow RO, Cannon RO, Leon MB, Epstein SE. Hypertrophic cardiomyopathy. Interrelations of clinical manifestations, pathophysiology, and therapy. N Engl J Med 1987; 316: 780-789.
29. McKenna WJ, Franklin RCG, Nihoyannopoulos P, et al. Arrhythmia and prognosis in infants, children, and adolescents with hypertrophic cardiomyopathy. J Am Coll Cardiol 1988; 11: 147-153.
30. Fananapazir L, Tracy C, Leon MB, et al. Electrophysiologic abnormalities in patients with hypertrophic cardiomyopathy: a consecutive analysis of 155 patients. Circulation 1989; 80: 1259-1268.
31. Fananapazir L, Cannon RO, Tripodi D, Panza JA. Impact of dual chamber permanent pacing in patients with obstructive hypertrophic cardiomyopathy with symptoms refractory to verapamil and beta adrenergic blocker therapy. Circulation 1992; 85: 2149-2161.
32. Alday LE, Bruno E, Moreyra E, Amuchastegui LM, Juaneda E, Maisuls H. Mid term results of dual-chamber pacing in children with hypertrophic obstructive cardiomyopathy. Echocardiography 1998; 15: 289-295.
33. Yetman AT, McCrindle BW, MacDonald C, Freedom RM, Gow R. Myocardial briging in children with hypertrophic cardiomyopathy - A risk factor for sudden death. N Engl J Med 1998; 339: 1201-1209.
34. Spirito P, Bellone P, Harris KM, Bernabo P, Bruzzi P, Maron BJ. Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy. N Engl J Med 2000; 342: 1778-1785.
35. Maron BJ, Shen WK, Link MS, et al. Efficacy of implantable cardioverter - defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy. New Engl J Med 2000; 342: 365-373.
36. Stone CD, McIntosh CL, Hennein HA, Maron BJ, Clark RE. Operative treatment of pediatric obstructive hypertrophic cardiomyopathy: A 26-year experience. Ann Thorac Surg 1993; 56: 1308-1314.
37. Shirani J, Maron BJ, Cannon RO, Shahin S, Roberts W. Clinicopathologic features of hypertrophic cardiomyopathy managed by cardiac transplantation. Am J Cardiol 1993; 72: 434-440.
38. McKenna WJ, Oakley CM, Krikler DM, Goodwin JF. Improved survival with amiodarone in patients with hypertrophic cardiomyopathy and ventricular tachycardia. Br Heart J 1985; 53: 412-416.
39. McKenna WJ, Deanfield JE. Hypertrophic cardiomyopathy. An important cause of sudden death. Arch Dis Childhood 1984; 59: 971-975.
40. McKenna WJ, Stewart JT. Management of arrhythmias in hypertrophic cardiomyopathy. ACC Curr J Review 1994; 3: 29-32.